Phase 4 Osteoporosis Trial, Recruiting NCT06938152 Sponsor: National Taiwan University Hospital Condition: Osteoporosis
Back to Osteoporosis

Phase 4 Osteoporosis Trial, Recruiting

NCT06938152
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has gone through menopause and are between 50 and 90 years old
  • Your bone density scan shows a T-score of -3.0 or lower in at least one bone in your lower spine (meaning significantly low bone density)
  • You are physically and mentally able to understand the study requirements and attend follow-up appointments
  • You are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • You have received any osteoporosis treatment in the past two years, including medications such as Romosozumab, Teriparatide, Denosumab, Alendronate, Ibandronate, Zoledronic Acid, Risedronate, Raloxifene, or Bazedoxifene
  • You have a known allergy to Romosozumab or Denosumab
  • Your bone loss is caused by another medical condition rather than menopause (confirm with trial site)
  • You have an autoimmune disease (a condition where the immune system attacks the body)
  • You regularly take steroid medications on a long-term basis, such as for a chronic lung condition
  • You have abnormally high or low calcium levels in your blood
  • You have another disease that affects how your bones are formed or maintained (confirm with trial site)
  • You have a bone tumour, whether originating in the bone or spread from elsewhere in the body
  • You currently have or have had cancer, unless it was a very early-stage skin cancer or you have been fully treated and cancer-free for at least five years
  • You are planning to have any dental procedures such as tooth extractions or implants within the next year
  • You have a history of heart stents, heart attack, stroke, or coronary artery disease
  • You have kidney disease or are on dialysis, including if your creatinine blood level is above 1.5 mg/dL (a measure of kidney function)
  • You currently smoke more than one pack of cigarettes per day, unless you have not smoked for more than ten years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 886-2312-3456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
8 April 2025
Est. completion
30 April 2029

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in bone mineral density (BMD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov